Effects of Placental Transfusion by Delayed Cord Clamping or Umbilical Cord Milking versus Immediate Cord Clamping on Neonatal Outcomes in Very Low Birth Weight Neonates
Effects of Placental Transfusion by Delayed Cord Clamping or Umbilical Cord Milking versus Immediate Cord Clamping on Neonatal Outcomes in Very Low Birth Weight Neonates作者机构:Division of Neonatology John H Stroger Hospital of Cook County Chicago IL USA Department of Pediatrics John H Stroger Hospital of Cook County Chicago IL USA Chicago Medical School at Rosalind Franklin University of Medical Sciences Chicago IL USA Division of Statistics Rush University Medical Center Chicago IL USA Department of Obstetrics and Gynecology John H Stroger Hospital of Cook County Chicago IL USA
出 版 物:《Open Journal of Obstetrics and Gynecology》 (妇产科期刊(英文))
年 卷 期:2018年第8卷第11期
页 面:1032-1039页
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题:Delayed Cord Clamping Umbilical Cord Milking Very Low Birth Weight Placental Transfusion
摘 要:Background: Delayed cord clamping (DCC) and umbilical cord milking (UCM) are two recently advocated interventions to enhance placental transfusion at birth. DCC and MCM might increase blood volume and help neonates to transition from fetal to neonatal circulation. Objective: To evaluate the effects of delayed cord clamping (DCC), umbilical cord milking (UCM), and immediate cord clamping (ICC) on very low birth weight (VLBW) neonates. Methods: At our institution, ICC was routinely done until December, 2012 when it was replaced by DCC. UCM was implemented in March, 2015. Neonatal outcomes were compared among ICC, DCC, and UCM. Results: A total of 94 neonates met inclusion criteria. Comparing with ICC neonates, DCC and UCM neonates had higher hematocrits, fewer blood transfusions, and lower incidence of chronic lung disease at 36 completed weeks of gestation. All groups were similar in APGAR scores, vasopressor use, intraventricular hemorrhage (IVH) and necrotizing enterocolitis (NEC). Conclusion: Compared to ICC, DCC and UCM appear to be more beneficial to VLBW neonates without apparent adverse risks.